Profil
Curtis Rambaran is currently Chief Medical Officer at Silence Therapeutics Plc since 2023.
Dr. Rambaran was Head-European Translational Medicine at Daiichi Sankyo UK Ltd. from 2016 to 2023.
Dr. Rambaran earned a doctorate from The University of the West Indies.
Aktive Positionen von Curtis Rambaran
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ehemalige bekannte Positionen von Curtis Rambaran
| Unternehmen | Position | Ende |
|---|---|---|
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 01.12.2023 |
Ausbildung von Curtis Rambaran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The University of the West Indies
The University of the West Indies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
















